VBI Vaccines, Inc. (VBIV) Flat As Market Sinks: What You Should KnowZacks Investment Research • 09/17/20
VBI Vaccines Announces Biomarker Data From VBI-1901 Phase 1/2a Study in Recurrent GBM Presented at ESMO Virtual Congress 2020Business Wire • 09/17/20
VBI Vaccines to Present Additional Biomarker Data from VBI-1901 Phase 1/2a Study in Recurrent GBM in an E-Poster at ESMO Virtual Congress 2020Business Wire • 09/14/20
VBI Vaccines, Inc. (VBIV) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 09/11/20
VBI Vaccines Picks 2 Coronavirus Vaccine Candidates for Further DevelopmentThe Motley Fool • 08/27/20
VBI Vaccines Announces Preclinical Coronavirus Program Data and Selection of Clinical Candidates with Potential as One-Dose VaccinesBusiness Wire • 08/26/20
VBI Vaccines Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral and Poster Presentations at EASL 2020Business Wire • 08/20/20
Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines for Coronavirus Vaccine CandidatesBusiness Wire • 08/18/20
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine DevelopmentBusiness Wire • 08/05/20
VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 07/31/20